Publications

Steve Finkbeiner, MD, PhDMonoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment. View in: PubMed
Steve Finkbeiner, MD, PhDPalop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007 Sep 6; 55(5):697-711. View in: PubMed
Steve Finkbeiner, MD, PhDCytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. View in: PubMed
Steve Finkbeiner, MD, PhDThe serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons. View in: PubMed
Steve Finkbeiner, MD, PhDPeebles CL, Finkbeiner S. RNA decay back in play. Nat Neurosci. 2007 Sep; 10(9):1083-4. View in: PubMed
Steve Finkbeiner, MD, PhDSingle neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease. View in: PubMed
Steve Finkbeiner, MD, PhDRao VR, Finkbeiner S. NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci. 2007 Jun; 30(6):284-91. View in: PubMed
Steve Finkbeiner, MD, PhDThe ubiquitin-proteasome pathway in Huntington's disease. View in: PubMed
Steve Finkbeiner, MD, PhDFinkbeiner S, Cuervo AM, Morimoto RI, Muchowski PJ. Disease-modifying pathways in neurodegeneration. J Neurosci. 2006 Oct 11; 26(41):10349-57. View in: PubMed
Steve Finkbeiner, MD, PhDAberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. View in: PubMed